HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial.
Li Q, Cheng Y, Tong Z, Liu Y, Wang X, Yan M, Chang J, Wang S, Du C, Li L, Wu C, Wang M, Wang Z, Wu Z, Wang X, Jin Y, Diao L, Sun Y, Zhang Y, Hui AM, Xu B.
Li Q, et al. Among authors: du c.
Nat Commun. 2024 Jun 17;15(1):5158. doi: 10.1038/s41467-024-48798-w.
Nat Commun. 2024.
PMID: 38886347
Clinical Trial.